Anna Pagonakis

Array ( [id] => 8797336 [patent_doc_number] => 08436205 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Tetrahydronaphthalene compounds' [patent_app_type] => utility [patent_app_number] => 13/125848 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10191 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651910 [patent_doc_number] => 20110301179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'NAPHTHAMIDES AS ANTICANCER AGENTS' [patent_app_type] => utility [patent_app_number] => 13/125289 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14351 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301179.pdf [firstpage_image] =>[orig_patent_app_number] => 13125289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637725 [patent_doc_number] => 20100035928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate' [patent_app_type] => utility [patent_app_number] => 12/580800 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2649 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035928.pdf [firstpage_image] =>[orig_patent_app_number] => 12580800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478106 [patent_doc_number] => 20100092388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Anthracycline Derivatives' [patent_app_type] => utility [patent_app_number] => 12/578380 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7296 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092388.pdf [firstpage_image] =>[orig_patent_app_number] => 12578380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685396 [patent_doc_number] => 20100120745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'ANTI-ANGIOGENIC AGENTS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/576483 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 10134 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120745.pdf [firstpage_image] =>[orig_patent_app_number] => 12576483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6359936 [patent_doc_number] => 20100087458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'METHOD OF TREATING MELANOMA' [patent_app_type] => utility [patent_app_number] => 12/575329 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4728 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087458.pdf [firstpage_image] =>[orig_patent_app_number] => 12575329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063461 [patent_doc_number] => 20110245295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'BIOACTIVE PRE-TUBULYSINS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/120497 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16714 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245295.pdf [firstpage_image] =>[orig_patent_app_number] => 13120497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9620955 [patent_doc_number] => 08791128 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-29 [patent_title] => 'Compositions for treating or delaying the onset of hair loss' [patent_app_type] => utility [patent_app_number] => 13/061159 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 5420 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13061159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710904 [patent_doc_number] => 08835473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Methods and compositions for treating cancer' [patent_app_type] => utility [patent_app_number] => 12/560119 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 11092 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12560119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6373050 [patent_doc_number] => 20100080855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'HEDGEHOG SIGNALING AND CANCER STEM CELLS IN HEMATOPOIETIC CELL MALIGNANCIES' [patent_app_type] => utility [patent_app_number] => 12/558429 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11279 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080855.pdf [firstpage_image] =>[orig_patent_app_number] => 12558429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464544 [patent_doc_number] => 20090324744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Effective Antitumor Treatments' [patent_app_type] => utility [patent_app_number] => 12/552347 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6530 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324744.pdf [firstpage_image] =>[orig_patent_app_number] => 12552347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304296 [patent_doc_number] => 20090298948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'COLCHICINE COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/545377 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24247 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298948.pdf [firstpage_image] =>[orig_patent_app_number] => 12545377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102730 [patent_doc_number] => 20110166223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'METHODS OF INHIBITING FGFR3 SIGNALING' [patent_app_type] => utility [patent_app_number] => 13/057975 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9106 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166223.pdf [firstpage_image] =>[orig_patent_app_number] => 13057975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6377984 [patent_doc_number] => 20100081646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'BICYCLIC HETEROARYL INHIBITORS OF PDE4' [patent_app_type] => utility [patent_app_number] => 12/544185 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45747 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081646.pdf [firstpage_image] =>[orig_patent_app_number] => 12544185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657379 [patent_doc_number] => 20110306648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'APOPTOSIS INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/059876 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4683 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306648.pdf [firstpage_image] =>[orig_patent_app_number] => 13059876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574041 [patent_doc_number] => 20110269697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/059176 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11112 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269697.pdf [firstpage_image] =>[orig_patent_app_number] => 13059176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039460 [patent_doc_number] => 20110092509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Pharmaceutical Composition for Prevention or Treatment of Disease Associated with Tear Reduction' [patent_app_type] => utility [patent_app_number] => 12/526298 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5188 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092509.pdf [firstpage_image] =>[orig_patent_app_number] => 12526298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495666 [patent_doc_number] => 20100010022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'CANCER TREATMENT METHOD' [patent_app_type] => utility [patent_app_number] => 12/536302 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18389 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010022.pdf [firstpage_image] =>[orig_patent_app_number] => 12536302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710338 [patent_doc_number] => 20120003270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => '6-SUBSTITUTED ISOFLAVONOID COMPOUNDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/056608 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19464 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13056608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490947 [patent_doc_number] => 20090292018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Dicarbonic Acid Derivatives, Metastasis Inhibitors and Agents Increasing Chemotherapeutic Activity of Anti-Tumor Preparations, Method for Enhancing the Cytostatic Efficiency and Metastasis Process Inhibiting Method' [patent_app_type] => utility [patent_app_number] => 12/511808 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1362 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20090292018.pdf [firstpage_image] =>[orig_patent_app_number] => 12511808 [rel_patent_id] =>[rel_patent_doc_number] =>)